Evaluation of COVID-19 fear and quality of life in patients with haematopoietic stem cell transplantation during the COVID-19 pandemic.

Serhat Çelik Zeynep Tuğba Güven Funda İpekten Muzaffer Keklik Ali Unal Leylagul Kaynar

Published in: European journal of cancer care (2022)

FCV-19S is a quick, safe and valid tool that can be used to determine the COVID-19 fear level in vulnerable patient groups such as HSCT patients and to direct them to the necessary psycho-oncological support.

Keyphrases

stem cell transplantation
coronavirus disease
sars cov
end stage renal disease
high dose
newly diagnosed
chronic kidney disease
peritoneal dialysis
prostate cancer
case report
radical prostatectomy
patient reported outcomes
hematopoietic stem cell
patient reported